Search results for "ACAT"

showing 10 items of 96 documents

Indacaterol vs tiotropium in COPD patients classified as GOLD A and B

2015

SummaryIntroductionAccording to current GOLD strategy, patients with COPD classified as groups A and B may be treated with inhaled bronchodilators, either long-acting β2-agonist (LABA) or long-acting muscarinic antagonist (LAMA). However, there is little guidance on which class of agent is preferred and a lack of prospective data to differentiate the two.MethodsIn this study, we performed post-hoc analyses of pooled data from two prospective, controlled clinical trials comparing the LABA indacaterol and LAMA tiotropium in 1422 patients with moderate airflow limitation and no history of exacerbations in the previous year. This population fits the definitions of GOLD A and B groups and could …

MalePulmonary and Respiratory MedicineEfficacyPopulationINDEXESQuinolonesOBSTRUCTIVE PULMONARY-DISEASEPulmonary Disease Chronic ObstructiveHumansMedicineCOPDCOHORTProspective StudiesGOLDTiotropium BromideeducationDYSPNEAIndacateroleducation.field_of_studyCOPDDose-Response Relationship Drugbiologybusiness.industryTiotropiumONCE-DAILY INDACATEROLMuscarinic antagonistForced Expiratory Flow RatesBaseline Dyspnea IndexMiddle AgedLamabiology.organism_classificationmedicine.diseaseBronchodilator Agentsrespiratory tract diseasesClinical trialTreatment OutcomeAnesthesiaIndansCohortIndacaterolFemalebusinessCLINICAL METHODSFollow-Up Studiesmedicine.drugRespiratory Medicine
researchProduct

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with mod…

2015

Background QVA149 is a once-daily (o.d.) inhaled dual bronchodilator containing a fixed-dose combination of the long-acting β2-agonist indacaterol and the long-acting muscarinic antagonist glycopyrronium for the treatment of COPD. The QUANTIFY study compared QVA149 with a free-dose bronchodilator combination of tiotropium plus formoterol (TIO+FOR) in improving health-related quality of life (HRQoL) of patients with COPD. Methods This multicentre, blinded, triple-dummy, parallel-group, non-inferiority study randomised patients aged ≥40 years with moderate-to-severe COPD (post-bronchodilator forced expiratory volume in 1 s (FEV1) ≥30% to <80% predicted) to QVA149 110/50 µg o.d. or TIO 18 µg o…

MalePulmonary and Respiratory MedicineVital capacitymedicine.drug_classChronic Obstructive Pulmonary DiseaseVital CapacityScopolamine DerivativesQuinolonesCOPD PharmacologyDrug Administration SchedulePulmonary Disease Chronic ObstructiveFEV1/FVC ratioDouble-Blind MethodQuality of lifeForced Expiratory VolumeFormoterol FumarateBronchodilatorHumansMedicine1506Tiotropium BromideAdrenergic beta-2 Receptor AgonistsAgedCOPDbusiness.industryMiddle Agedmedicine.diseaseGlycopyrrolateBronchodilator Agentsrespiratory tract diseasesDrug CombinationsTreatment OutcomeEthanolaminesBronchodilator AgentsAnesthesiaIndansQuality of LifeIndacaterolFemaleFormoterolbusinessmedicine.drugThorax
researchProduct

Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study

2011

SummaryBackgroundIndacaterol is a novel, inhaled once-daily ultra-long-acting β2-agonist for the treatment of COPD.MethodsThis 12-week randomised, parallel-group study compared the efficacy of indacaterol 150 μg once-daily to salmeterol 50 μg twice-daily in patients with moderate-to-severe COPD. Assessments included FEV1 standardised area under curve (AUC) from 5 min to 11 h 45 min at Week 12 (primary endpoint), 24-h trough FEV1 (mean of 23 h 10 min and 23 h 45 min post-dose) at Week 12 (key secondary endpoint), FEV1 and FVC measured over 24-h, transition dyspnoea index (TDI) and rescue medication use.ResultsOf 1123 patients randomised 92.1% completed. Mean ± SD age was 62.8 ± 8.78 years, p…

MalePulmonary and Respiratory Medicinemedicine.drug_classbeta2-agonistQuinolonesDrug Administration Schedulelaw.inventionFEV1/FVC ratioPulmonary Disease Chronic ObstructiveRandomized controlled trialDouble-Blind MethodlawBronchodilatorForced Expiratory VolumeClinical endpointmedicineCOPDHumansAlbuterolSalmeterolSalmeterol XinafoateIndacaterolCOPDDose-Response Relationship Drugbusiness.industryrespiratory systemMiddle Agedmedicine.diseaserespiratory tract diseasesBronchodilator AgentsRespiratory Function TestsTreatment OutcomeAnesthesiaIndansIndacaterolFemaleSalmeterolOnce dailybusinessBronchodilatormedicine.drugRespiratory Medicine
researchProduct

GOLD 2017 treatment pathways in ‘real life’: An analysis of the DACCORD observational study

2017

Abstract Introduction The 2017 update to the Global Initiative for Obstructive Lung Disease (GOLD) strategy document includes recommendations for treatment intensification or step-down in chronic obstructive pulmonary disease (COPD), although recognises that limited supporting information is available. DACCORD is an ongoing observational, non-interventional study, recruiting patients following COPD maintenance treatment change or initiation, a subset of whom were receiving a long-acting β2-agonist (LABA) plus a long-acting muscarinic antagonist (LAMA) fixed-dose combination (FDC) on entry. Since there were no requirements in terms of prior medication (and no washout before commencing LABA/L…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyExacerbationmedicine.drug_classMuscarinic AntagonistsQuinolonesMaintenance ChemotherapyPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicinePharmacotherapyAdrenal Cortex HormonesGermanyInternal medicineAdministration InhalationmedicineHumansddc:610Longitudinal StudiesProspective Studies030212 general & internal medicineAdrenergic beta-2 Receptor AgonistsAgedCOPDbiologybusiness.industryDisease ManagementMiddle AgedLamabiology.organism_classificationmedicine.diseaseGlycopyrrolateObstructive lung diseaseDrug Combinations030228 respiratory systemIndansPractice Guidelines as TopicCritical PathwaysDisease ProgressionPhysical therapyIndacaterolCorticosteroidDrug Therapy CombinationFemaleObservational studybusinesshormones hormone substitutes and hormone antagonistsmedicine.drugRespiratory Medicine
researchProduct

Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in…

2014

BACKGROUND: To further assess the safety profile of the fixed-dose combination of indacaterol and glycopyrronium (QVA149) and its monocomponents; we investigated the impact of individual patient-level factors and time by integrating the patient-level safety data from the QVA149 clinical programme with relevant information from the independent indacaterol and glycopyrronium safety databases.METHODS: Data from 11,404 patients with chronic obstructive pulmonary disease (COPD) were pooled from 14 clinical studies of QVA149, indacaterol and glycopyrronium of ≥3 month's duration with at least two of the treatment groups: QVA149 110/50 μg, glycopyrronium 50 μg, indacaterol 150 μg, placebo or tiotr…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyFixed-dose combinationScopolamine DerivativesQuinolonesPlaceboPooled analysisPulmonary Disease Chronic ObstructiveRisk FactorsInternal medicinemedicineHumansTiotropium BromideIndacaterolAgedCOPDbusiness.industryTiotropiumHazard ratioQVA149Middle Agedmedicine.diseaseGlycopyrrolateConfidence intervalBronchodilator AgentsDrug CombinationsTreatment OutcomeAnesthesiaIndansIndacaterolDrug Therapy CombinationFemaleGlycopyrroniumSafetybusinessBody mass indexMacemedicine.drugRespiratory Medicine
researchProduct

C2C interactions creating value in the Route of Santiago

2016

The role of interaction between customers (customer-to-customer; C2C) is a key factor when extracting value from a touristic experience. Several studies incorporate quantitative and qualitative aspects referring to interactions and can provide a holistic view about C2C experiences, being therefore more capable of predicting the effects of C2C interaction on customer behavior. This study analyzes C2C interactions in backpackers’ experience and their effect on the cruise experience and vacation satisfaction. The study uses fuzzy-set qualitative comparative analysis (fsQCA) to explore a causal relationship with dichotomous outcomes, both the presence and the absence of the variables. The study…

MarketingValue co-creationVacation satisfactionQualitative comparative analysis05 social sciencesQualitative comparative analysisC2C0502 economics and businessORGANIZACION DE EMPRESASfsQCA050211 marketingRoute of SantiagoValence (psychology)MarketingPsychology050212 sport leisure & tourismConsumer behaviourCustomer-to-customer interactionJournal of Business Research
researchProduct

La vessatorietà della provvigione del mediatore in caso di recesso del venditore

2021

La Corte di Cassazione conferma il precedente orientamento favorevole a qualificare come vessatorie le clausole, pattuite nei contratti di mediazione, con le quali le agenzie immobiliari si assicurano il diritto alla provvigione anche in caso di mancata conclusione dell’affare. La soluzione avallata dalla Corte – che nello specifico, per il caso di recesso del venditore, commina la nullita` consumeristica alla clausola con cui il mediatore ottenga un compenso, a prescindere da una commisurazione all’attivita` svolta – si espone, tuttavia, al rischio di traghettare il giudizio di vessatorieta` sulla sponda di un inammissibile sindacato sull’equilibrio economico dello scambio.

Mediazione atipicaSindacato di vessatorietàMandato di mediazione immobiliareClausole vessatorieSquilibrio normativo ed economicoMediazioneSettore IUS/01 - Diritto PrivatoMancata conclusione dell'affareSindacato sulle clausole vessatorieProvvigione
researchProduct

La casa fra gli alberi

2013

L'articolo descrive il lavoro degli architetti Anne Lacaton e Jean Philippe Vassal a Cap Ferret

Natura e abitare Lacaton e Vassal
researchProduct

La escritura en la Cartuja (análisis diacrónico a través de las constituciones)

1983

PaleografíaConstituciones eclesiásticasUNESCO::HISTORIA::Historia por épocas::Historia antiguaCartujos:HISTORIA::Historia por épocas::Historia antigua [UNESCO]MonacatoScriptoriumEscritura
researchProduct

NUTRITIONAL AND HORMONAL FACTORS AFFECTING FRUIT SET IN AVOCADO (Persea americana Mill.)

2017

Under favourable conditions, the avocado sets more fruits than the tree is able to bring to maturity, so that the plant adjusts, during the early stages of development, its ability to nourish them by modifying their number, that is, causing the fruit drop of those who can not maintain their growth rate. Accordingly, carbohydrate availability could be a key factor in the physiological abscission of these fruits. Since this species presents dichogamy, the abscission of fruits has also been attributed to the absence of pollination, but at the same time it has been related to failures in seed development, embryo abortion, seed coat collapse, and with the effect of an environmental stress, espec…

PerseaAguacatecuajadocarbohidratosabscisiónPaclobutrazolchemistry.chemical_compoundAbscissionAnthesisAuxinGibberellic acidFRUIT SET carbohydrate physiological abscission competition hormonal content.Paniclechemistry.chemical_classificationbiologydicogamiafood and beverageshormonas.biology.organism_classificationSettore AGR/03 - Arboricoltura Generale E Coltivazioni ArboreeHorticulturechemistryShootfrutoscompetencia
researchProduct